{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T00:04:27Z","timestamp":1717891467246},"reference-count":22,"publisher":"Japanese Pharmacological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Pharmacologica Japonica","Folia Pharmacol. Jpn."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1254\/fpj.145.250","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T22:01:49Z","timestamp":1431208909000},"page":"250-258","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacological characteristics and clinical results of efinaconazole (Clenafin<sup>\u00ae<\/sup> Topical Solution 10%), a novel anti-onychomycosis drug"],"prefix":"10.1254","volume":"145","author":[{"given":"Yoshiyuki","family":"Tatsumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2) Watanabe S, et al. J Dermatol. 2010;37:397-406.","DOI":"10.1111\/j.1346-8138.2009.00741.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"6) Grover C, et al. Mycoses. 2012;55:541-551.","DOI":"10.1111\/j.1439-0507.2012.02199.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"8) Tatsumi Y, et al. Antimicrob Agents Chemother. 2002;46:3797-3801.","DOI":"10.1128\/AAC.46.12.3797-3801.2002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"9) Sugiura K, et al. Antimicrobial Agents Chemother. 2013;58:3837-3842.","DOI":"10.1128\/AAC.00111-14"},{"key":"5","doi-asserted-by":"crossref","unstructured":"10) Narasimha Murthy S, et al. J Pharm Sci. 2007;96:305-311.","DOI":"10.1002\/jps.20757"},{"key":"6","doi-asserted-by":"crossref","unstructured":"11) Ogura H, et al. Chem Pharm Bull. 1999;47:1417-1425.","DOI":"10.1248\/cpb.47.1417"},{"key":"7","unstructured":"12) Bhatt V, et al. Annual Meeting of Am Acad Dermatol. 2013."},{"key":"8","doi-asserted-by":"crossref","unstructured":"13) Tatsumi Y, et al. Antimicrob Agents Chemother. 2013;57:2405-2409.","DOI":"10.1128\/AAC.02063-12"},{"key":"9","doi-asserted-by":"crossref","unstructured":"14) Jo Siu WJ, et al. Antimicrobial Agents Chemother. 2013;57:1610-1616.","DOI":"10.1128\/AAC.02056-12"},{"key":"10","unstructured":"15) Sakamoto M, et al. J Drugs Dermatol. 2014;13:1388-1392."},{"key":"11","unstructured":"16) National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved standard Second edition M38-A2. Wayne: CLSI; 2008."},{"key":"12","unstructured":"17) National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard Third edition M27-A3. Wayne: CLSI; 2008."},{"key":"13","doi-asserted-by":"crossref","unstructured":"21) Traynor MJ, et al. J Pharm Pharmacol. 2010;62:730-737.","DOI":"10.1211\/jpp.62.06.0009"},{"key":"14","doi-asserted-by":"crossref","unstructured":"22) Iwata A, et al. Antimicrob Agents Chemother. 2014;58:4920-4922.","DOI":"10.1128\/AAC.02703-13"},{"key":"15","unstructured":"23) Jarratt M, et al. J Drugs Dermatol. 2013;12:1010-1016."},{"key":"16","doi-asserted-by":"crossref","unstructured":"24) Elewski BE, et al. J Am Acad Dermatol. 2013;68:600-608.","DOI":"10.1016\/j.jaad.2012.10.013"},{"key":"17","doi-asserted-by":"crossref","unstructured":"26) Elewski BE. Expert Rev Dermatol. 2013;8:347-356.","DOI":"10.1586\/17469872.2013.814872"},{"key":"18","doi-asserted-by":"crossref","unstructured":"27) Elewski BE. Expert Opin Pharmacother. 2014;15:1439-1448.","DOI":"10.1517\/14656566.2014.921158"},{"key":"19","doi-asserted-by":"crossref","unstructured":"28) Gupta AK, et al. J Am Acad Dermatol. 2000;43 Suppl:S70-S80.","DOI":"10.1067\/mjd.2000.109071"},{"key":"20","unstructured":"29) Elewski BE, et al. J Eur Acad Dermatol Venereol. 2013;27:287-294."},{"key":"21","unstructured":"30) Sporanox (itraconazole) [prescribing information]. Titusville: Janssen; 2014."},{"key":"22","doi-asserted-by":"crossref","unstructured":"31) Evans EGV, et al. BMJ. 1999;318:1031-1035.","DOI":"10.1136\/bmj.318.7190.1031"}],"container-title":["Folia Pharmacologica Japonica"],"original-title":["\u65b0\u898f\u722a\u767d\u766c\u6cbb\u7642\u85ac\u30a8\u30d5\u30a3\u30ca\u30b3\u30ca\u30be\u30fc\u30eb\uff08\u30af\u30ec\u30ca\u30d5\u30a3\u30f3<sup>\u00ae<\/sup>\u722a\u5916\u7528\u6db210\uff05\uff09\u306e\u85ac\u7406\u5b66\u7684\u7279\u6027\u3068\u81e8\u5e8a\u8a66\u9a13\u6210\u7e3e"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/145\/5\/145_250\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T22:20:01Z","timestamp":1717885201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/145\/5\/145_250\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1254\/fpj.145.250","relation":{},"ISSN":["0015-5691","1347-8397"],"issn-type":[{"value":"0015-5691","type":"print"},{"value":"1347-8397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}